These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 30676992)
1. The Potential Impact of Alzheimer's Disease Early Treatment on Societal Costs of Care in Czechia: A Simulation Approach. Broulikova HM; Sladek V; Arltova M; Cerny J J Ment Health Policy Econ; 2018 Dec; 21(4):147-161. PubMed ID: 30676992 [TBL] [Abstract][Full Text] [Related]
2. The cost of treatment of Alzheimer's disease in The Netherlands: a regression-based simulation model. McDonnell J; Redekop WK; van der Roer N; Goes E; Ruitenberg A; Busschbach JJ; Breteler MM; Rutten FF Pharmacoeconomics; 2001; 19(4):379-90. PubMed ID: 11383754 [TBL] [Abstract][Full Text] [Related]
3. Potential cost savings to be made by slowing cognitive decline in mild Alzheimer's disease dementia using a model derived from the UK GERAS observational study. Lenox-Smith A; Reed C; Lebrec J; Belger M; Jones RW BMC Geriatr; 2018 Feb; 18(1):57. PubMed ID: 29471784 [TBL] [Abstract][Full Text] [Related]
4. Potential cost savings in residential care for Alzheimer's disease patients. Leon J; Moyer D Gerontologist; 1999 Aug; 39(4):440-9. PubMed ID: 10495582 [TBL] [Abstract][Full Text] [Related]
5. Economic evaluation of galantamine in the treatment of mild to moderate Alzheimer's disease in the United States. Migliaccio-Walle K; Getsios D; Caro JJ; Ishak KJ; O'Brien JA; Papadopoulos G; Clin Ther; 2003 Jun; 25(6):1806-25. PubMed ID: 12860500 [TBL] [Abstract][Full Text] [Related]
6. The economic burden of the care and treatment for people with Alzheimer's disease: the outlook for the Czech Republic. Marešová P; Zahálková V Neurol Sci; 2016 Dec; 37(12):1917-1922. PubMed ID: 27470305 [TBL] [Abstract][Full Text] [Related]
7. Early identification and treatment of Alzheimer's disease: social and fiscal outcomes. Weimer DL; Sager MA Alzheimers Dement; 2009 May; 5(3):215-26. PubMed ID: 19362885 [TBL] [Abstract][Full Text] [Related]
8. An economic evaluation of early assessment for Alzheimer's disease in the United Kingdom. Getsios D; Blume S; Ishak KJ; Maclaine G; Hernández L Alzheimers Dement; 2012 Jan; 8(1):22-30. PubMed ID: 21420366 [TBL] [Abstract][Full Text] [Related]
9. Cost and care of patients with Alzheimer's disease: clinical predictors in German health care settings. Reese JP; Hessmann P; Seeberg G; Henkel D; Hirzmann P; Rieke J; Baum E; Dannhoff F; Müller MJ; Jessen F; Geldsetzer MB; Dodel R J Alzheimers Dis; 2011; 27(4):723-36. PubMed ID: 21876256 [TBL] [Abstract][Full Text] [Related]
10. Prospective one-year cost-of-illness study in a cohort of patients with dementia of Alzheimer's disease type in Spain: the ECO study. Coduras A; Rabasa I; Frank A; Bermejo-Pareja F; López-Pousa S; López-Arrieta JM; Del Llano J; León T; Rejas J J Alzheimers Dis; 2010; 19(2):601-15. PubMed ID: 20110605 [TBL] [Abstract][Full Text] [Related]
11. Cost-Effectiveness of Florbetapir-PET in Alzheimer's Disease: A Spanish Societal Perspective. Hornberger J; Michalopoulos S; Dai M; Andrade P; Dilla T; Happich M J Ment Health Policy Econ; 2015 Jun; 18(2):63-73. PubMed ID: 26231002 [TBL] [Abstract][Full Text] [Related]
12. Economic cost of Alzheimer disease in Israel. Beeri MS; Werner P; Adar Z; Davidson M; Noy S Alzheimer Dis Assoc Disord; 2002; 16(2):73-80. PubMed ID: 12040302 [TBL] [Abstract][Full Text] [Related]
13. The cost of Alzheimer's disease in managed care: a cross-sectional study. Leon J; Neumann PJ Am J Manag Care; 1999 Jul; 5(7):867-77. PubMed ID: 10557408 [TBL] [Abstract][Full Text] [Related]
14. Patients with Alzheimer's disease living at home in France: costs and consequences of the disease. Rigaud AS; Fagnani F; Bayle C; Latour F; Traykov L; Forette F J Geriatr Psychiatry Neurol; 2003 Sep; 16(3):140-5. PubMed ID: 12967055 [TBL] [Abstract][Full Text] [Related]
15. How to deal with missing longitudinal data in cost of illness analysis in Alzheimer's disease-suggestions from the GERAS observational study. Belger M; Haro JM; Reed C; Happich M; Kahle-Wrobleski K; Argimon JM; Bruno G; Dodel R; Jones RW; Vellas B; Wimo A BMC Med Res Methodol; 2016 Jul; 16():83. PubMed ID: 27430559 [TBL] [Abstract][Full Text] [Related]
16. Determinants of costs of care for patients with Alzheimer's disease. Jönsson L; Eriksdotter Jönhagen M; Kilander L; Soininen H; Hallikainen M; Waldemar G; Nygaard H; Andreasen N; Winblad B; Wimo A Int J Geriatr Psychiatry; 2006 May; 21(5):449-59. PubMed ID: 16676288 [TBL] [Abstract][Full Text] [Related]
17. Quantifying and Describing the Natural History and Costs of Alzheimer's Disease and Effects of Hypothetical Interventions. Wimo A; Handels R; Winblad B; Black CM; Johansson G; Salomonsson S; Eriksdotter M; Khandker RK J Alzheimers Dis; 2020; 75(3):891-902. PubMed ID: 32390617 [TBL] [Abstract][Full Text] [Related]
18. Design of comprehensive Alzheimer's disease centers to address unmet national needs. Trojanowski JQ; Arnold SE; Karlawish JH; Brunden K; Cary M; Davatzikos C; Detre J; Gaulton G; Grossman M; Hurtig H; Jedrziewski K; McCluskey L; Naylor M; Polsky D; Schellenberg GD; Siderowf A; Shaw LM; Van Deerlin V; Wang LS; Werner R; Xie SX; Lee VM Alzheimers Dement; 2010 Mar; 6(2):150-5. PubMed ID: 20298979 [TBL] [Abstract][Full Text] [Related]
19. Cost analysis of early psychosocial intervention in Alzheimer's disease. Søgaard R; Sørensen J; Waldorff FB; Eckermann A; Buss DV; Waldemar G Dement Geriatr Cogn Disord; 2014; 37(3-4):141-53. PubMed ID: 24157706 [TBL] [Abstract][Full Text] [Related]